The Best AI Stock to Own in the World Today is Trading for Just $25

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

NRIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $350,992.37

Nurix Therapeutics Insider Trading History Chart

Nurix Therapeutics Share Price & Price History

^$13.98

▼ -0.18 (-1.27%)

As of 05/8/2024 01:00 AM ET

Days: 30 | 90 | 365

The Weight Loss Pill That Could Disrupt a $32 Billion Industry

From Behind the Markets | Ad

A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.

Don't miss out on the "next Ozempic" >>>

Nurix Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/2/2024	Houte Hans Van	CFO	Sell	3,499	$12.83	$44,892.17	68,333
4/30/2024	Gwenn Hansen	Insider	Sell	2,007	$12.04	$24,164.28	39,601
4/30/2024	Houte Hans Van	CFO	Sell	1,387	$12.04	$16,699.48	71,832
2/16/2024	Houte Hans Van	CFO	Sell	6,812	$10.02	$68,256.24	68,333
1/30/2024	Gwenn Hansen	Insider	Sell	2,334	$7.99	$18,648.66	36,402
1/30/2024	Houte Hans Van	CFO	Sell	1,671	$7.99	$13,351.29	75,145
12/19/2023	Houte Hans Van	CFO	Sell	10,906	$10.00	$109,060.00	75,471
10/31/2023	Christine Ring	Insider	Sell	1,232	$5.20	$6,406.40	15,263
10/31/2023	Houte Hans Van	CFO	Sell	1,080	$5.20	$5,616.00	86,377
7/31/2023	Christine Ring	General Counsel	Sell	1,420	$9.65	$13,703.00	12,544
7/31/2023	Gwenn Hansen	Insider	Sell	1,884	$9.65	$18,180.60	29,955
7/31/2023	Houte Hans Van	CFO	Sell	1,245	$9.65	$12,014.25	82,571
5/1/2023	Christine Ring	General Counsel	Sell	682	$9.88	$6,738.16	10,040
5/1/2023	Gwenn Hansen	Insider	Sell	1,136	$9.88	$11,223.68	26,632
5/1/2023	Houte Hans Van	CFO	Sell	721	$9.88	$7,123.48	78,930
5/1/2023	Stefani Wolff	COO	Sell	342	$9.88	$3,378.96	6,113
1/30/2023	Christine Ring	General Counsel	Sell	848	$11.78	$9,989.44	7,261
1/30/2023	Gwenn Hansen	Insider	Sell	1,412	$11.78	$16,633.36	23,009
1/30/2023	Houte Hans Van	CFO	Sell	924	$11.78	$10,884.72	76,765
1/30/2023	Stefani Wolff	COO	Sell	424	$11.78	$4,994.72	3,940
10/31/2022	Christine Ring	General Counsel	Sell	699	$12.88	$9,003.12	6,185
10/31/2022	Gwenn Hansen	Insider	Sell	1,165	$12.88	$15,005.20	21,214
10/31/2022	Houte Hans Van	CFO	Sell	739	$12.88	$9,518.32	74,803
10/31/2022	Stefani Wolff	COO	Sell	350	$12.88	$4,508.00	3,402
8/1/2022	Christine Ring	General Counsel	Sell	712	$15.67	$11,157.04	4,615
8/1/2022	Gwenn Hansen	Insider	Sell	1,186	$15.67	$18,584.62	19,172
8/1/2022	Houte Hans Van	CFO	Sell	752	$15.67	$11,783.84	72,656
8/1/2022	Stefani Wolff	COO	Sell	356	$15.67	$5,578.52	1,238
5/2/2022	Christine Ring	General Counsel	Sell	660	$11.75	$7,755.00	3,403
5/2/2022	Gwenn Hansen	Insider	Sell	1,098	$11.75	$12,901.50	17,151
5/2/2022	Houte Hans Van	CFO	Sell	697	$11.75	$8,189.75	2,189
5/2/2022	Stefani Wolff	COO	Sell	330	$11.75	$3,877.50	632
12/10/2021	Christine Ring	General Counsel	Sell	1,200	$29.04	$34,848.00
12/1/2021	Gwenn Hansen	Insider	Sell	400	$29.13	$11,652.00
11/1/2021	Gwenn Hansen	Insider	Sell	400	$33.24	$13,296.00
10/27/2021	Christine Ring	General Counsel	Sell	800	$35.25	$28,200.00
10/27/2021	Gwenn Hansen	Insider	Sell	400	$35.00	$14,000.00
10/11/2021	Christine Ring	General Counsel	Sell	1,200	$27.36	$32,832.00
10/1/2021	Gwenn Hansen	Insider	Sell	400	$29.92	$11,968.00
9/7/2021	Christine Ring	General Counsel	Sell	3,200	$35.25	$112,800.00
9/7/2021	Gwenn Hansen	Insider	Sell	1,600	$35.00	$56,000.00	15,797
8/10/2021	Christine Ring	General Counsel	Sell	1,200	$29.87	$35,844.00	2,005
8/10/2021	Pierre Beaurang	Insider	Sell	7,500	$29.86	$223,950.00
8/2/2021	Gwenn Hansen	Insider	Sell	400	$31.21	$12,484.00	14,204
7/20/2021	Christine Ring	General Counsel	Sell	1,200	$27.00	$32,400.00
7/12/2021	Pierre Beaurang	Insider	Sell	7,500	$23.92	$179,400.00	11,830
6/10/2021	Christine Ring	General Counsel	Sell	1,200	$29.40	$35,280.00	2,005
6/10/2021	Pierre Beaurang	Insider	Sell	7,500	$29.37	$220,275.00	11,830
6/1/2021	Gwenn Hansen	Insider	Sell	400	$27.74	$11,096.00	14,204
5/10/2021	Christine Ring	General Counsel	Sell	1,200	$27.00	$32,400.00	2,005

The new financial threat that could wipe out millions…

From InvestorPlace | Ad

During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.

Pay close attention to this important video

SEC Filings (Institutional Ownership Changes) for Nurix Therapeutics (NASDAQ:NRIX)

Institutional Buying and Selling by Quarter

Nurix Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/8/2024	ProShare Advisors LLC	11,978	$0.18M	0.0%	+9.1%	0.024%
5/8/2024	Russell Investments Group Ltd.	53,542	$0.79M	0.0%	+75.6%	0.109%
5/7/2024	49 Wealth Management LLC	12,503	$0.18M	0.0%	-8.7%	0.025%
5/7/2024	SG Americas Securities LLC	22,194	$0.33M	0.0%	-16.6%	0.045%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	30,904	$0.45M	0.0%	+27.3%	0.063%
4/30/2024	J.W. Cole Advisors Inc.	18,028	$0.27M	0.0%	N/A	0.037%
4/29/2024	Principal Financial Group Inc.	12,953	$0.19M	0.0%	-8.4%	0.026%
4/29/2024	China Universal Asset Management Co. Ltd.	9,404	$0.14M	0.0%	+67.6%	0.019%
4/18/2024	Wasatch Advisors LP	1,236,753	$18.18M	0.1%	-55.0%	2.516%
4/5/2024	Los Angeles Capital Management LLC	102,321	$1.50M	0.0%	-18.8%	0.208%
3/5/2024	Wellington Management Group LLP	205,324	$2.12M	0.0%	+41.6%	0.420%
2/14/2024	Pennant Investors LP	56,800	$0.59M	0.1%	N/A	0.117%
2/14/2024	Wasatch Advisors LP	2,749,745	$28.38M	0.2%	-22.9%	5.670%
2/13/2024	Affinity Asset Advisors LLC	690,112	$7.12M	1.3%	+176.0%	1.423%
2/12/2024	Hsbc Holdings PLC	67,323	$0.70M	0.0%	+40.1%	0.139%
2/9/2024	Quest Partners LLC	5,725	$59K	0.0%	N/A	0.012%
2/9/2024	Trexquant Investment LP	159,318	$1.64M	0.0%	+80.9%	0.328%
2/8/2024	Massachusetts Financial Services Co. MA	142,146	$1.47M	0.0%	+248.2%	0.293%
2/7/2024	Jump Financial LLC	15,332	$0.16M	0.0%	N/A	0.032%
2/6/2024	Charles Schwab Investment Management Inc.	622,297	$6.42M	0.0%	+9.4%	1.283%
2/5/2024	AtonRa Partners	21,102	$0.22M	0.4%	-12.9%	0.044%
2/1/2024	New York State Common Retirement Fund	16,156	$0.17M	0.0%	+59.5%	0.033%
1/25/2024	International Assets Investment Management LLC	12,126	$1.18M	0.0%	N/A	0.025%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	24,276	$0.25M	0.0%	-11.3%	0.050%
1/24/2024	International Assets Investment Management LLC	12,126	$1.18M	0.0%	N/A	0.025%
1/24/2024	China Universal Asset Management Co. Ltd.	5,611	$58K	0.0%	+351.0%	0.012%
1/19/2024	Denali Advisors LLC	57,500	$0.59M	0.2%	N/A	0.119%
1/17/2024	ARK Investment Management LLC	3,194,999	$32.97M	0.2%	+23.2%	6.588%
1/16/2024	Raymond James & Associates	101,006	$1.04M	0.0%	+3.1%	0.208%
1/12/2024	SG Americas Securities LLC	26,601	$0.28M	0.0%	+28.9%	0.055%
1/5/2024	Exchange Traded Concepts LLC	15,823	$0.16M	0.0%	+34.0%	0.033%
12/19/2023	Public Employees Retirement System of Ohio	36,138	$0.28M	0.0%	-58.0%	0.075%
12/18/2023	Vanguard Group Inc.	2,714,845	$21.34M	0.0%	+0.8%	5.598%
12/6/2023	Citigroup Inc.	42,200	$0.33M	0.0%	-10.1%	0.087%
12/1/2023	Wellington Management Group LLP	145,053	$1.14M	0.0%	+3.0%	0.299%
11/15/2023	GSA Capital Partners LLP	195,420	$1.54M	0.1%	+1,012.4%	0.403%
11/15/2023	Redmile Group LLC	2,848,827	$22.39M	1.1%	-0.3%	5.874%
11/15/2023	Kennedy Capital Management LLC	163,623	$1.29M	0.0%	+192.7%	0.337%
11/15/2023	Affinity Asset Advisors LLC	250,000	$1.97M	0.6%	+150.0%	0.515%
11/14/2023	Trexquant Investment LP	88,066	$0.69M	0.0%	+57.7%	0.182%
11/14/2023	Profund Advisors LLC	17,233	$0.14M	0.0%	-18.9%	0.036%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	183,923	$1.45M	0.0%	+40.9%	0.379%
11/13/2023	Hsbc Holdings PLC	48,065	$0.38M	0.0%	+40.0%	0.099%
11/13/2023	FMR LLC	320,907	$2.52M	0.0%	-23.0%	0.662%
11/13/2023	Rafferty Asset Management LLC	98,839	$0.78M	0.0%	-13.7%	0.204%
11/8/2023	Charles Schwab Investment Management Inc.	568,576	$4.47M	0.0%	+48.1%	1.172%
11/8/2023	Massachusetts Financial Services Co. MA	40,826	$0.32M	0.0%	+96.2%	0.084%
11/8/2023	Swiss National Bank	84,800	$0.67M	0.0%	-3.5%	0.175%
11/6/2023	Los Angeles Capital Management LLC	125,839	$0.99M	0.0%	+15.6%	0.259%
11/2/2023	Principal Financial Group Inc.	15,531	$0.12M	0.0%	+14.8%	0.032%
10/31/2023	Panagora Asset Management Inc.	18,171	$0.14M	0.0%	-79.6%	0.037%
10/25/2023	AtonRa Partners	24,227	$0.19M	0.4%	-19.6%	0.050%
10/24/2023	Bank of New York Mellon Corp	170,286	$1.34M	0.0%	+2.9%	0.351%
10/24/2023	Raymond James & Associates	97,988	$0.77M	0.0%	+6.0%	0.202%
10/18/2023	ARK Investment Management LLC	2,593,047	$20.38M	0.2%	+14.7%	5.346%
10/13/2023	SG Americas Securities LLC	20,639	$0.16M	0.0%	N/A	0.043%
8/21/2023	Affinity Asset Advisors LLC	100,000	$1M	0.3%	-33.3%	0.207%
8/15/2023	Suvretta Capital Management LLC	280,760	$2.81M	0.1%	N/A	0.582%
8/14/2023	Jefferies Financial Group Inc.	62,000	$0.62M	0.0%	N/A	0.129%
8/14/2023	Graham Capital Management L.P.	10,783	$0.11M	0.0%	N/A	0.022%
8/11/2023	Natixis	5,779	$58K	0.0%	-18.4%	0.012%
8/11/2023	B. Metzler seel. Sohn & Co. AG	54,076	$0.54M	0.0%	+211.9%	0.112%
8/11/2023	Trexquant Investment LP	55,854	$0.56M	0.0%	+60.7%	0.116%
8/11/2023	ExodusPoint Capital Management LP	41,718	$0.42M	0.0%	N/A	0.087%
8/10/2023	Profund Advisors LLC	21,249	$0.21M	0.0%	-19.4%	0.044%
8/8/2023	Candriam S.C.A.	1,019,822	$10.19M	0.1%	+13.3%	2.116%
8/8/2023	Wasatch Advisors LP	3,869,775	$38.66M	0.2%	+21.9%	8.029%
8/3/2023	Los Angeles Capital Management LLC	108,850	$1.09M	0.0%	+4.9%	0.226%
8/3/2023	Innovis Asset Management LLC	15,648	$0.16M	0.1%	-47.9%	0.032%
8/3/2023	Bank of New York Mellon Corp	165,470	$1.65M	0.0%	+4.5%	0.343%
8/1/2023	Arizona State Retirement System	11,327	$0.11M	0.0%	+10.6%	0.024%
7/25/2023	Raymond James & Associates	92,441	$0.92M	0.0%	+35.9%	0.192%
7/24/2023	Allspring Global Investments Holdings LLC	5,264	$53K	0.0%	+328.7%	0.011%
7/20/2023	Exchange Traded Concepts LLC	12,339	$0.12M	0.0%	N/A	0.026%
7/18/2023	Allspring Global Investments Holdings LLC	5,264	$53K	0.0%	+328.7%	0.011%
7/18/2023	AtonRa Partners	30,142	$0.30M	0.5%	-8.5%	0.063%
7/10/2023	ARK Investment Management LLC	2,261,071	$22.59M	0.1%	+0.9%	4.766%
5/15/2023	Affinity Asset Advisors LLC	150,000	$1.33M	0.4%	+87.5%	0.316%
5/11/2023	Avalon Trust Co	7,056	$63K	0.0%	N/A	0.015%
5/10/2023	B. Metzler seel. Sohn & Co. AG	17,337	$0.15M	0.0%	+35.3%	0.037%
5/10/2023	Innovis Asset Management LLC	30,045	$0.27M	0.1%	N/A	0.063%
5/10/2023	Pictet Asset Management SA	1,064,838	$9.46M	0.0%	+10.6%	2.245%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	13,048	$0.12M	0.0%	N/A	0.028%
5/9/2023	Tower Research Capital LLC TRC	11,104	$99K	0.0%	+1,488.6%	0.023%
5/9/2023	Russell Investments Group Ltd.	36,676	$0.33M	0.0%	+52.3%	0.077%
5/5/2023	AtonRa Partners	32,934	$0.29M	0.4%	-10.8%	0.069%
5/4/2023	Barclays PLC	72,147	$0.64M	0.0%	-27.6%	0.152%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	29,537	$0.26M	0.0%	+21.8%	0.062%
5/4/2023	Los Angeles Capital Management LLC	103,779	$0.92M	0.0%	-2.5%	0.219%
5/3/2023	Jump Financial LLC	12,100	$0.11M	0.0%	-52.1%	0.026%
5/2/2023	Amalgamated Bank	4,708	$42K	0.0%	-19.4%	0.010%
4/27/2023	Arizona State Retirement System	10,245	$91K	0.0%	N/A	0.022%
4/17/2023	ARK Investment Management LLC	2,239,859	$19.89M	0.1%	+12.7%	4.721%
4/14/2023	Raymond James & Associates	68,011	$0.60M	0.0%	+33.3%	0.143%
2/14/2023	Alpine Global Management LLC	10,989	$0.12M	0.0%	N/A	0.023%
2/13/2023	GSA Capital Partners LLP	27,967	$0.31M	0.0%	N/A	0.059%
2/13/2023	Cornercap Investment Counsel Inc.	18,756	$0.21M	0.0%	N/A	0.040%
2/9/2023	Denali Advisors LLC	5,900	$65K	0.0%	+63.9%	0.013%
2/9/2023	Citigroup Inc.	73,596	$0.81M	0.0%	-38.9%	0.156%
2/8/2023	Swiss National Bank	85,200	$0.94M	0.0%	+7.8%	0.181%

Data available starting January 2016

Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and cell therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-2127, an orally bioavailable Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications. It is also developing NX-0479/GS-6791, a IRAK4 degrader for the treatment of rheumatoid arthritis and other inflammatory diseases. The company has a strategic collaboration agreement with Gilead Sciences, Inc., Sanofi S.A., and Seagen Inc. co-development and co-commercialization for multiple drug candidates. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.

Today's Range

Now: $13.98

$13.56

$14.31

50 Day Range

MA: $13.94

$11.91

$17.48

52 Week Range

Now: $13.98

$4.22

$18.12

Volume

476,636 shs

Average Volume

934,453 shs

Market Capitalization

$687.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.1

Who are the company insiders with the largest holdings of Nurix Therapeutics?: Nurix Therapeutics' top insider investors include:
Houte Hans Van (CFO)
Gwenn Hansen (Insider)
Christine Ring (Insider)
Christine Ring (General Counsel)
Stefani Wolff (COO)
Learn More about top insider investors at Nurix Therapeutics.
Who are the major institutional investors of Nurix Therapeutics?: Nurix Therapeutics' top institutional investors include:
Wasatch Advisors LP — 2.52%
Los Angeles Capital Management LLC — 0.21%
Russell Investments Group Ltd. — 0.11%
Mirae Asset Global Investments Co. Ltd. — 0.06%
SG Americas Securities LLC — 0.05%
J.W. Cole Advisors Inc. — 0.04%
Learn More about top institutional investors of Nurix Therapeutics stock.
Which institutional investors are selling Nurix Therapeutics stock?: During the last quarter, NRIX stock was sold by these institutional investors:
Wasatch Advisors LP
Los Angeles Capital Management LLC
SG Americas Securities LLC
49 Wealth Management LLC
Principal Financial Group Inc.
Within the last year, company insiders that have sold Nurix Therapeutics company stock include:
Houte Hans Van (CFO)
Gwenn Hansen (Insider)
Christine Ring (Insider)
Christine Ring (General Counsel)
Learn More investors selling Nurix Therapeutics stock.
Which institutional investors are buying Nurix Therapeutics stock?: Within the previous quarter, NRIX stock was purchased by institutional investors including:
Russell Investments Group Ltd.
J.W. Cole Advisors Inc.
Mirae Asset Global Investments Co. Ltd.
China Universal Asset Management Co. Ltd.
ProShare Advisors LLC